Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00109785 · ClinicalTrials.gov registry record · Phase 1
PET Scans in Patients With Locally Advanced Breast Cancer
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT00109785: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00109785 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00109785, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
RATIONALE: Imaging procedures such as PET scans may improve the ability to monitor the effectiveness of chemotherapy for locally advanced breast cancer. PURPOSE: This clinical trial is studying how well PET scans work in patients with locally advanced breast cancer who will undergo chemotherapy.
Interventions
- RADIATION fludeoxyglucose F 18
- PROCEDURE positron emission tomography
- RADIATION iodine I 124 iododeoxyuridine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 1997-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00109785
The ClinicalTrials.gov registry entry for NCT00109785 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fludeoxyglucose F 18 is the first listed.
NCT00109785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00109785 about?
NCT00109785 is a clinical study titled "PET Scans in Patients With Locally Advanced Breast Cancer". RATIONALE: Imaging procedures such as PET scans may improve the ability to monitor the effectiveness of chemotherapy for locally advanced breast cancer. PURPOSE: This clinical trial is studying how well PET scans work in patients with locally advanced breast cancer who will undergo chemotherapy.
What is the current status of trial NCT00109785?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 1997-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00109785?
The interventions under investigation include: fludeoxyglucose F 18 (RADIATION), positron emission tomography (PROCEDURE), iodine I 124 iododeoxyuridine (RADIATION).
Who is sponsoring clinical trial NCT00109785?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.